Related Experiment Video

Updated: Apr 26, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

miR‑210 regulates esophageal cancer cell proliferation by inducing G2/M phase cell cycle arrest through targeting

Chenglin Li1, Xinliang Zhou2, Yadi Wang1

  • 1Department of Radiation Oncology, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China.

Molecular Medicine Reports
|July 30, 2014
PubMed

Insights

MicroRNAs (miRNAs) regulate protein expression. This study found miR-210 inhibits esophageal squamous cell carcinoma (ESCC) proliferation by targeting PLK1, leading to cell cycle arrest.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression.
  • miRNAs are emerging as potential therapeutic targets in various cancers.
  • Esophageal squamous cell carcinoma (ESCC) is a significant global health concern.

Purpose of the Study:

  • To investigate the role of miR-210 in esophageal squamous cell carcinoma (ESCC).
  • To determine the effect of miR-210 on ESCC cell proliferation and cell cycle.
  • To identify the molecular mechanism underlying miR-210's function in ESCC.

Main Methods:

  • Quantification of circulating miR-210 levels in ESCC patients.
  • In vitro studies using cell counting kit-8 and bromodeoxyuridine incorporation assays.
  • Analysis of cell cycle progression and target gene validation (PLK1) via mRNA and protein analysis.

Main Results:

  • Elevated circulating miR-210 levels were observed in ESCC patients.
  • miR-210 significantly inhibited ESCC cell proliferation.
  • miR-210 induced G2/M phase cell cycle arrest by targeting Polo-like kinase 1 (PLK1).

Conclusions:

  • miR-210 acts as a tumor suppressor in ESCC.
  • The miR-210/PLK1 axis is a critical regulator of ESCC cell proliferation and cell cycle.
  • miR-210 represents a potential therapeutic target for ESCC treatment.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

10.8K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

26.6K

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K